Literature DB >> 19933855

In a murine tuberculosis model, the absence of homeostatic chemokines delays granuloma formation and protective immunity.

Shabaana A Khader1, Javier Rangel-Moreno, Jeffrey J Fountain, Cynthia A Martino, William W Reiley, John E Pearl, Gary M Winslow, David L Woodland, Troy D Randall, Andrea M Cooper.   

Abstract

Mycobacterium tuberculosis infection (Mtb) results in the generation of protective cellular immunity and formation of granulomatous structures in the lung. CXCL13, CCL21, and CCL19 are constitutively expressed in the secondary lymphoid organs and play a dominant role in the homing of lymphocytes and dendritic cells. Although it is known that dendritic cell transport of Mtb from the lung to the draining lymph node is dependent on CCL19/CCL21, we show in this study that CCL19/CCL21 is also important for the accumulation of Ag-specific IFN-gamma-producing T cells in the lung, development of the granuloma, and control of mycobacteria. Importantly, we also show that CXCL13 is not required for generation of IFN-gamma responses, but is essential for the spatial arrangement of lymphocytes within granulomas, optimal activation of phagocytes, and subsequent control of mycobacterial growth. Furthermore, we show that these chemokines are also induced in the lung during the early immune responses following pulmonary Mtb infection. These results demonstrate that homeostatic chemokines perform distinct functions that cooperate to mediate effective expression of immunity against Mtb infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19933855      PMCID: PMC2799945          DOI: 10.4049/jimmunol.0901937

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  34 in total

1.  A novel mutant gene involved in T-lymphocyte-specific homing into peripheral lymphoid organs on mouse chromosome 4.

Authors:  H Nakano; S Mori; H Yonekawa; H Nariuchi; A Matsuzawa; T Kakiuchi
Journal:  Blood       Date:  1998-04-15       Impact factor: 22.113

2.  Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin.

Authors:  A G Bean; D R Roach; H Briscoe; M P France; H Korner; J D Sedgwick; W J Britton
Journal:  J Immunol       Date:  1999-03-15       Impact factor: 5.422

3.  A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes.

Authors:  M D Gunn; K Tangemann; C Tam; J G Cyster; S D Rosen; L T Williams
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-06       Impact factor: 11.205

4.  Cutting edge: secondary lymphoid-tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes.

Authors:  H Saeki; A M Moore; M J Brown; S T Hwang
Journal:  J Immunol       Date:  1999-03-01       Impact factor: 5.422

5.  Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5.

Authors:  Christopher D C Allen; K Mark Ansel; Caroline Low; Robin Lesley; Hirokazu Tamamura; Nobutaka Fujii; Jason G Cyster
Journal:  Nat Immunol       Date:  2004-08-01       Impact factor: 25.606

6.  Differential regulation of CCL21 in lymphoid/nonlymphoid tissues for effectively attracting T cells to peripheral tissues.

Authors:  James C Lo; Robert K Chin; Youjin Lee; Hyung-Sik Kang; Yang Wang; Joel V Weinstock; Theresa Banks; Carl F Ware; Guido Franzoso; Yang-Xin Fu
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

7.  Cutting edge: the B cell chemokine CXC chemokine ligand 13/B lymphocyte chemoattractant is expressed in the high endothelial venules of lymph nodes and Peyer's patches and affects B cell trafficking across high endothelial venules.

Authors:  Yukihiko Ebisuno; Toshiyuki Tanaka; Naotoshi Kanemitsu; Hidenobu Kanda; Kazuhito Yamaguchi; Tsuneyasu Kaisho; Shizuo Akira; Masayuki Miyasaka
Journal:  J Immunol       Date:  2003-08-15       Impact factor: 5.422

8.  B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5.

Authors:  D F Legler; M Loetscher; R S Roos; I Clark-Lewis; M Baggiolini; B Moser
Journal:  J Exp Med       Date:  1998-02-16       Impact factor: 14.307

9.  Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization.

Authors:  M D Gunn; S Kyuwa; C Tam; T Kakiuchi; A Matsuzawa; L T Williams; H Nakano
Journal:  J Exp Med       Date:  1999-02-01       Impact factor: 14.307

10.  Chemokines and the homing of dendritic cells to the T cell areas of lymphoid organs.

Authors:  J G Cyster
Journal:  J Exp Med       Date:  1999-02-01       Impact factor: 14.307

View more
  63 in total

1.  A novel nanoemulsion vaccine induces mucosal Interleukin-17 responses and confers protection upon Mycobacterium tuberculosis challenge in mice.

Authors:  Mushtaq Ahmed; Douglas M Smith; Tarek Hamouda; Javier Rangel-Moreno; Ali Fattom; Shabaana A Khader
Journal:  Vaccine       Date:  2017-07-31       Impact factor: 3.641

2.  IL-23 is required for long-term control of Mycobacterium tuberculosis and B cell follicle formation in the infected lung.

Authors:  Shabaana A Khader; Lokesh Guglani; Javier Rangel-Moreno; Radha Gopal; Beth A Fallert Junecko; Jeffrey J Fountain; Cynthia Martino; John E Pearl; Michael Tighe; Yin-yao Lin; Samantha Slight; Jay K Kolls; Todd A Reinhart; Troy D Randall; Andrea M Cooper
Journal:  J Immunol       Date:  2011-10-14       Impact factor: 5.422

Review 3.  Immunological mechanisms contributing to the double burden of diabetes and intracellular bacterial infections.

Authors:  Kelly Hodgson; Jodie Morris; Tahnee Bridson; Brenda Govan; Catherine Rush; Natkunam Ketheesan
Journal:  Immunology       Date:  2015-02       Impact factor: 7.397

Review 4.  The role of B cells and humoral immunity in Mycobacterium tuberculosis infection.

Authors:  John Chan; Simren Mehta; Sushma Bharrhan; Yong Chen; Jacqueline M Achkar; Arturo Casadevall; JoAnne Flynn
Journal:  Semin Immunol       Date:  2014-10-28       Impact factor: 11.130

5.  A review of computational and mathematical modeling contributions to our understanding of Mycobacterium tuberculosis within-host infection and treatment.

Authors:  Denise Kirschner; Elsje Pienaar; Simeone Marino; Jennifer J Linderman
Journal:  Curr Opin Syst Biol       Date:  2017-05-22

Review 6.  Mouse model of tuberculosis.

Authors:  Andrea M Cooper
Journal:  Cold Spring Harb Perspect Med       Date:  2014-09-25       Impact factor: 6.915

7.  CXCL5-secreting pulmonary epithelial cells drive destructive neutrophilic inflammation in tuberculosis.

Authors:  Geraldine Nouailles; Anca Dorhoi; Markus Koch; Jens Zerrahn; January Weiner; Kellen C Faé; Frida Arrey; Stefanie Kuhlmann; Silke Bandermann; Delia Loewe; Hans-Joachim Mollenkopf; Alexis Vogelzang; Catherine Meyer-Schwesinger; Hans-Willi Mittrücker; Gayle McEwen; Stefan H E Kaufmann
Journal:  J Clin Invest       Date:  2014-02-10       Impact factor: 14.808

Review 8.  The development and function of mucosal lymphoid tissues: a balancing act with micro-organisms.

Authors:  T D Randall; R E Mebius
Journal:  Mucosal Immunol       Date:  2014-02-26       Impact factor: 7.313

9.  Long-Lasting Impact of Neonatal Exposure to Total Body Gamma Radiation on Secondary Lymphoid Organ Structure and Function.

Authors:  Javier Rangel-Moreno; Maria de la Luz Garcia-Hernandez; Rosalio Ramos-Payan; Jamie Biear; Eric Hernady; Mark Y Sangster; Troy D Randall; Carl J Johnston; Jacob N Finkelstein; Jacqueline P Williams
Journal:  Radiat Res       Date:  2015-09-23       Impact factor: 2.841

10.  CXCR5⁺ T helper cells mediate protective immunity against tuberculosis.

Authors:  Samantha R Slight; Javier Rangel-Moreno; Radha Gopal; Yinyao Lin; Beth A Fallert Junecko; Smriti Mehra; Moises Selman; Enrique Becerril-Villanueva; Javier Baquera-Heredia; Lenin Pavon; Deepak Kaushal; Todd A Reinhart; Troy D Randall; Shabaana A Khader
Journal:  J Clin Invest       Date:  2013-01-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.